Pharmacological correction of plasma redox potential and endothelial dysfunction in ischemic heart failure

Pharmacological correction of plasma redox potential and endothelial dysfunction in ischemic heart failure

Aim. To study the role of plasma redox potential reduction in the development of endothelial dysfunction (ED) among patients with chronic heart failure (CHF) and to investigate the potential of its pharmacological correction. Material and methods. This randomised cohort study included 73 patients wi...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. P. Donetskaya, V. A. Tulupova, N. V. Shuldeshova, M. M. Fedorova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2012-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronary heart disease heart failure redox potential endothelial dysfunction adenocin nicotinamide adenine dinucleotide
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1699
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Title: Identification of Redox State Based on the Difference in Solvation Dynamics
by: Yasuhiro Kato, et al.
Published: (2025-05-01)

Review on Biosynthesis of β-Nicotinamide Mononucleotide and Its Derivatives
by: WANG Zhaoying, GUO Xinhao, HUANG Xinhe, CHEN Zhuoyan, LIU Yueqi, LI Juan, CHEN Ning, FAN Xiaoguang
Published: (2025-07-01)

Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men
by: Shintaro Yamaguchi, et al.
Published: (2024-02-01)

Nicotinamide Adenine Dinucleotide Supplementation Improves Cuprizone‐Induced Multiple Sclerosis‐Related Behavioral Changes in C57BL/6J Mice
by: Shuang Song, et al.
Published: (2025-05-01)

Pharmacological correction of pro- and anti-inflammatory cytokine induction and energy metabolism system state in patients with coronary heart disease and chronic heart failure
by: V. E. Malikov, et al.
Published: (2011-10-01)

Tissue-specific effects of bacterial PncA overexpression on NAD+ metabolism and aging in mice: implications for tissue-specific aging interventions
by: Fengjiao Huo, et al.
Published: (2025-04-01)

Evaluation of the zinc succinate toxic eﬀect on the cerebral cortex of rat
by: G. A. Piavchenko, et al.
Published: (2019-06-01)

Decrease of NAD+ Inhibits the Apoptosis of OLP T Cells via Inducing Mitochondrial Fission
by: Zhang ZY, et al.
Published: (2025-01-01)

Comprehensive analysis through multi-omics integration to compare and elucidate the specific substances in milk of donkey、horse、camel、human and pig
by: Qiu Zhang, et al.
Published: (2025-05-01)

Nicotinamide mononucleotide protects ovarian function and oocyte developmental competence during chemotherapy
by: Lin Shen, et al.
Published: (2025-08-01)

Erythrocyte nicotinamide adenine dinucleotide concentration is enhanced by systematic sports participation
by: Barbara Pospieszna, et al.
Published: (2024-10-01)

A mixed-mode LC-MS-based method for comprehensive analysis of NAD and related metabolites from biological sample matrices
by: Omprakash Nacham, et al.
Published: (2025-04-01)

High-intensity intermittent exercise regulates oxidative stress and improves endothelial progenitor cell function in patients with essential hypertension
by: Jixin ZHI, et al.
Published: (2025-02-01)

Differentially abundant proteins, metabolites, and lipid molecules in spaghetti meat compared to normal chicken breast meat: Multiomics analysis
by: Janghan Choi, et al.
Published: (2025-07-01)

Targeting NAD + biosynthesis suppresses TGF-β1/Smads/RAB26 axis and potentiates cisplatin cytotoxicity in non-small cell lung cancer brain metastasis
by: Liyun Zhou, et al.
Published: (2025-03-01)

Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial
by: Woo Hyun Paik, et al.
Published: (2025-01-01)

NADK as a molecular marker to distinguish between alcohol- and non-alcohol-associated liver cirrhosis: A pilot study
by: Ki-Hoon Park, et al.
Published: (2025-03-01)

Oxidative Stress: Pathological Driver in Chronic Neurodegenerative Diseases
by: Zhao Zhong Chong, et al.
Published: (2025-06-01)

Neuronal C/EBPβ Shortens the Lifespan via Inactivating NAMPT
by: Bowei Li, et al.
Published: (2025-06-01)

Suppression of NOX2-Derived Reactive Oxygen Species (ROS) Reduces Epithelial-to-MesEnchymal Transition Through Blocking SiO<sub>2</sub>-Regulated JNK Activation
by: Guanhan Xiang, et al.
Published: (2025-04-01)

IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension
by: Zongye Cai, et al.
Published: (2025-08-01)

Homozygous Methemoglobinemia Course in a 2-Year-Old Girl
by: Marina S. Malyugina, et al.
Published: (2023-03-01)

FSP1 and CoQ10 have the potential to serve as biomarkers for severe preeclampsia
by: Peishan LI, et al.
Published: (2025-08-01)

MiR-367-3p Alleviates Oxidative Stress Injury in the Ischemia/Reperfusion Injury Cell Model by Targeting Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4-mediated Keap1/Nrf2/ARE Pathway
by: Qian He, et al.
Published: (2025-05-01)

Derangement in Nicotinamide Adenine Dinucleotide Metabolism is Observed During Acute Kidney Injury Among Male Agricultural Workers at Risk for Mesoamerican Nephropathy
by: Nathan H. Raines, et al.
Published: (2024-07-01)

ENDOTHELIAL DYSFUNCTION AND “OXIDATIVE STRESS” BY THE NONNSTABLE COURSE OF ISCHEMIC HEART DISEASE
by: A. E. Kratnov, et al.
Published: (2014-07-01)

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients
by: Ch. A. Abdullaeva, et al.
Published: (2016-02-01)

ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2016-01-01)

Biochemical algorithms of early diagnostic of metabolic remodeling and cardiac hypertrophy in patients with diabetic mellitus and chronic heart failure cause by ischemic heart disease
by: O. P. Donetskaya, et al.
Published: (2019-08-01)

THE INFLUENCE OF CORONARY BYPASS ON ENDOTHELIAL AND ERECTILE DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: S. A. Pomeshkina, et al.
Published: (2015-01-01)

ENDOTHELIAL DYSFUNCTION AND ROLE NITRATES AND BETA-BLOCKERS IN ITS CORRECTION IN ISCHEMIC HEART DISEASE
by: A. N. Britov
Published: (2016-05-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)

On the utility of immobilized phenylarsine oxide in the study of redox sensitive cardiac proteins
by: Asvi Arora Francois, et al.
Published: (2025-05-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

Obesity-induced arterial redox imbalance involving mitochondrial NOX4, endothelial dysfunction, and ER stress underlie kidney injury compensated by enhanced mitochondrial bioenergetics
by: Cristina Contreras, et al.
Published: (2025-09-01)

Endothelial dysfunction in heart failure with normal systolic function, and its correction with a metabolic agent, mildronate
by: V. P. Geychenko, et al.
Published: (2005-08-01)

Dextran sulfate sodium-induced colitis exacerbates periodontitis via the NADPH oxidase 2/reactive oxygen species axis in M1-like macrophages
by: Tiansong Xu, et al.
Published: (2025-04-01)

ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS
by: M. M. Petina, et al.
Published: (2011-04-01)